Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 16 2022 | Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease Industry News In The News Industry Read More Mar 14 2022 | New Episode of the Heart Failure Beat Explores Guideline-Directed Medical Therapy in HF – Evidence vs. Practicality HFSA News Podcasts Provider Education Read More Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News HFSA Annual Scientific Meeting HFSA Awards Research Read More Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Mar 16 2022 | Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease Industry News In The News Industry Read More
Mar 14 2022 | New Episode of the Heart Failure Beat Explores Guideline-Directed Medical Therapy in HF – Evidence vs. Practicality HFSA News Podcasts Provider Education Read More
Mar 9 2022 | The definition of heart failure—a patient’s perspective Patient News Heart Failure Awareness 365 Patient Resource Read More
Mar 2 2022 | US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Industry News In The News Industry Read More
Mar 1 2022 | Heart Failure Collaboratory (HFC)/HFSA Joint Site-Based Research Awards Call for 2022 Nominations Practice News HFSA Annual Scientific Meeting HFSA Awards Research Read More
